Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

What is Teva really worth?
Globes, Israel
Sunday, August 7, 2011 - 11:44am
tags:
Teva Pharmaceuticals
Dr Reddy's expects North American biz to drive growth this FY
Economic Times, India
Sunday, August 7, 2011 - 11:43am
tags:
Dr Reddy's
Generic drug industry slams special deal in patent reform bill
The Hill
Sunday, August 7, 2011 - 11:41am
tags:
generics
India's Aurobindo Pharma posts 1Q loss
MarketWatch
Saturday, August 6, 2011 - 1:56pm
tags:
Aurobindo, earnings
Qiagen Completes Second U.S. Submission For Companion Diagnostic To Guide Treatment Decisions In Colorectal Cancer
Biomed Reports
Saturday, August 6, 2011 - 1:53pm
tags:
Qiagen, KRAS assay, Erbitux, colorectal cancer
HHS-OIG Drops Potential Action against Forest CEO Howard Solomon
MarketWatch
Saturday, August 6, 2011 - 1:51pm
tags:
OIG, investigations, legal, Forest Labs
Enzon Inc. Reports Operating Results (10-Q)
GuruFocus
Saturday, August 6, 2011 - 1:29pm
tags:
Enzon, earnings
U.K. rejects MS drug over cost
Yahoo/Investor's Business Daily
Saturday, August 6, 2011 - 1:26pm
tags:
Novartis, multiple sclerosis, Gilenya
Novo Nordisk Revenues Up
Yahoo/Zacks
Saturday, August 6, 2011 - 1:25pm
tags:
Novo Nordisk, earnings
Lower Spending Boosts Par Pharma
Yahoo/Zacks
Saturday, August 6, 2011 - 1:24pm
tags:
Par Pharmaceutical
Big Pharma: M&A Spells Disaster for R&D
Seeking Alpha
Saturday, August 6, 2011 - 1:23pm
tags:
M&A, R&D
Momenta's earnings rise on market grab from Sanofi
bizjournals
Saturday, August 6, 2011 - 1:22pm
tags:
Momenta, Lovenox, Sanofi, generics
Surviving the Biotech Selloff (video)
The Street
Saturday, August 6, 2011 - 1:08pm
tags:
Sequenom's CEO Discusses Q2 2011 Results - Earnings Call Transcript
Seeking Alpha
Saturday, August 6, 2011 - 1:04pm
tags:
Sequenom, earnings
Halozyme Therapeutics Shares Popped: What You Need to Know
Motley Fool
Saturday, August 6, 2011 - 1:04pm
tags:
Halozyme, ViroPharma, Baxter International, rHuPH20
Loss at MannKind Wider than Expected
Yahoo/Zacks
Saturday, August 6, 2011 - 1:02pm
tags:
MannKind, earnings
Still Want to Be the Next Dendreon?
Motley Fool
Saturday, August 6, 2011 - 1:01pm
tags:
Dendreon, Vertex Pharmaceuticals, Incivek, hepatitis B
Doctor Who Is a Provenge Fan Says Reimbursement Is a Risk
Seeking Alpha
Saturday, August 6, 2011 - 12:59pm
tags:
Dendreon, Provenge
InterMune Loss Rise, Costs Flare Up
Yahoo/Zacks
Saturday, August 6, 2011 - 12:58pm
tags:
InterMune
Levi & Korsinsky Notifies Investors With Losses on Their Investment in Dendreon Corporation of Class Action Lawsuit and the October 4, 2011 Lead Plaintiff Deadline
Yahoo/MarketWire
Saturday, August 6, 2011 - 12:57pm
tags:
Dendreon, lawsuits

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.